WEST PHARMACEUTICAL SERVICES INC (WST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 300M 600M 900M Q3 '21: 706.5M Q4 '21: 730.8M Q1 '22: 720M Q2 '22: 771.3M Q3 '22: 686.9M Q4 '22: 708.7M Q1 '23: 716.6M Q2 '23: 753.8M Q3 '23: 747.4M Q4 '23: 732M Q1 '24: 695.4M Q2 '24: 702.1M Q3 '24: 746.9M Q4 '24: 748.8M Q1 '25: 698M Q2 '25: 766.5M Q3 '25: 804.6M Q4 '25: 805M Q1 '26: 844.9M Q2 '26: 872.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 150M 300M 450M Q3 '21: 288.2M Q4 '21: 300.6M Q1 '22: 284.6M Q2 '22: 321.5M Q3 '22: 268M Q4 '22: 262.1M Q1 '23: 271.3M Q2 '23: 291.4M Q3 '23: 288.3M Q4 '23: 278.2M Q1 '24: 230.2M Q2 '24: 230M Q3 '24: 264.7M Q4 '24: 273.6M Q1 '25: 231.9M Q2 '25: 273.9M Q3 '25: 294.3M Q4 '25: 303.9M Q1 '26: 296.4M Q2 '26: 329.2M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

0 80M 160M 240M Q3 '21: 181.4M Q4 '21: 184M Q1 '22: 189.7M Q2 '22: 228.4M Q3 '22: 186.2M Q4 '22: 129.7M Q1 '23: 155.3M Q2 '23: 182.5M Q3 '23: 177.3M Q4 '23: 160.9M Q1 '24: 122.8M Q2 '24: 126.2M Q3 '24: 161.3M Q4 '24: 159.6M Q1 '25: 107M Q2 '25: 153.7M Q3 '25: 167.6M Q4 '25: 156.6M Q1 '26: 177.1M Q2 '26: 179.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

0 70M 140M 210M Q3 '21: 175.6M Q4 '21: 147.7M Q1 '22: 173.8M Q2 '22: 188.5M Q3 '22: 120.6M Q4 '22: 103M Q1 '23: 140M Q2 '23: 155.1M Q3 '23: 161.3M Q4 '23: 137M Q1 '24: 115.3M Q2 '24: 111.3M Q3 '24: 136M Q4 '24: 130.1M Q1 '25: 89.8M Q2 '25: 131.8M Q3 '25: 140M Q4 '25: 132.1M Q1 '26: 138.8M Q2 '26: 154M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 200M 400M 600M Q3 '21: 418.3M Q4 '21: 430.2M Q1 '22: 435.4M Q2 '22: 449.8M Q3 '22: 418.9M Q4 '22: 446.6M Q1 '23: 445.3M Q2 '23: 462.4M Q3 '23: 459.1M Q4 '23: 453.8M Q1 '24: 465.2M Q2 '24: 472.1M Q3 '24: 482.2M Q4 '24: 475.2M Q1 '25: 466.1M Q2 '25: 492.6M Q3 '25: 510.3M Q4 '25: 501.1M Q1 '26: 548.5M Q2 '26: 543.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

0 90M 180M 270M Q3 '21: 190.1M Q4 '21: 160.8M Q1 '22: 151.2M Q2 '22: 173.1M Q3 '22: 168.9M Q4 '22: 230.8M Q1 '23: 138.1M Q2 '23: 169.2M Q3 '23: 230.1M Q4 '23: 239.1M Q1 '24: 118.2M Q2 '24: 165M Q3 '24: 180.1M Q4 '24: 190.1M Q1 '25: 129.4M Q2 '25: 177.1M Q3 '25: 197.2M Q4 '25: 251.1M Q1 '26: 89.9M Q2 '26: 124M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

0 60M 120M 180M Q3 '21: 124.8M Q4 '21: 84.3M Q1 '22: 85.4M Q2 '22: 107M Q3 '22: 111.1M Q4 '22: 135.9M Q1 '23: 56M Q2 '23: 93.8M Q3 '23: 134.3M Q4 '23: 130.4M Q1 '24: 27.6M Q2 '24: 64.8M Q3 '24: 98.8M Q4 '24: 85.2M Q1 '25: 58.1M Q2 '25: 101.9M Q3 '25: 133.9M Q4 '25: 175M Q1 '26: 47.2M Q2 '26: 80.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '20: 75.5M Q2 '20: 75.5M Q3 '20: 75.8M Q1 '21: 75.8M Q2 '21: 75.7M Q3 '21: 76M Q1 '22: 76M Q2 '22: 75.8M Q3 '22: 75.7M Q1 '23: 75.7M Q2 '23: 75.4M Q3 '23: 75.3M Q1 '24: 74.3M Q2 '24: 73.7M Q3 '24: 73.4M Q1 '25: 73M Q2 '25: 72.5M Q3 '25: 72.6M Q1 '26: 72.4M Q2 '26: 71.3M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

0.00 3.50 7.00 10.50 Q3 '21: 8.06 Q4 '21: 8.66 Q1 '22: 8.96 Q2 '22: 8.97 Q3 '22: 8.25 Q4 '22: 7.73 Q1 '23: 7.29 Q2 '23: 6.87 Q3 '23: 7.42 Q4 '23: 7.88 Q1 '24: 7.58 Q2 '24: 7.03 Q3 '24: 6.74 Q4 '24: 6.69 Q1 '25: 6.37 Q2 '25: 6.68 Q3 '25: 6.75 Q4 '25: 6.79 Q1 '26: 7.48 Q2 '26: 7.81 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.